Lower-cost biotech drug gets thumbs up from FDA panel (Update)
The second-biggest selling drug in the world could get some cheaper competition in the U.S., after a federal panel endorsed an alternative version of the pricey medication used to treat rheumatoid arthritis and other inflammatory ...
Jul 12, 2016
0
1